<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/38C7C4D6-29BB-4D46-858D-9E3A40B7CD1B"><gtr:id>38C7C4D6-29BB-4D46-858D-9E3A40B7CD1B</gtr:id><gtr:name>Sphere Fluidics Limited</gtr:name><gtr:address><gtr:line1>THE JONAS WEBB BUILDING BABRAHAM RESEARCH CAMPUS , BABRAHAM</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/38C7C4D6-29BB-4D46-858D-9E3A40B7CD1B" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>38C7C4D6-29BB-4D46-858D-9E3A40B7CD1B</gtr:id><gtr:name>Sphere Fluidics Limited</gtr:name><gtr:address><gtr:line1>THE JONAS WEBB BUILDING BABRAHAM RESEARCH CAMPUS , BABRAHAM</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>191866.0</gtr:offerGrant><gtr:projectCost>319776.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/15EE80F3-B18B-442A-B27D-7DD4CA6550C6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>15EE80F3-B18B-442A-B27D-7DD4CA6550C6</gtr:id><gtr:name>MedImmune Limited</gtr:name><gtr:address><gtr:line1>Medimmune
Milstein Building
Granta Park</gtr:line1><gtr:city>Cambridge</gtr:city><gtr:postCode>CB21 6GH</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>42543.0</gtr:offerGrant><gtr:projectCost>85086.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C49BE6FF-661F-44CC-9DF3-3EB053E9231C"><gtr:id>C49BE6FF-661F-44CC-9DF3-3EB053E9231C</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Holmes</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101789"><gtr:id>66901477-0470-4C18-974F-8DB1C99924D9</gtr:id><gtr:title>A novel, single cell characterisation, dispensing and imaging platform for accelerated biopharmaceutical development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101789</gtr:grantReference><gtr:abstractText>Sphere Fluidics Limited is an SME focusing on the development of novel, single cell analysis technologies. MedImmune, the global biopharmaceuticals arm of AstraZeneca, is a pioneer in biopharmaceutical discovery and development. Both companies have pooled their synergistic, science skills to propose the development of a unique, integrated microfluidic instrument that uses miniaturisation and novel chips to process pools of cells and rapidly isolate single cells for applications in biopharmaceutical research and development.</gtr:abstractText><gtr:fund><gtr:end>2015-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2014-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>234409</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101789</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>